These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8636122)

  • 1. Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.
    Shire D; Calandra B; Delpech M; Dumont X; Kaghad M; Le Fur G; Caput D; Ferrara P
    J Biol Chem; 1996 Mar; 271(12):6941-6. PubMed ID: 8636122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.
    Shire D; Calandra B; Bouaboula M; Barth F; Rinaldi-Carmona M; Casellas P; Ferrara P
    Life Sci; 1999; 65(6-7):627-35. PubMed ID: 10462063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.
    Rinaldi-Carmona M; Pialot F; Congy C; Redon E; Barth F; Bachy A; Brelière JC; Soubrié P; Le Fur G
    Life Sci; 1996; 58(15):1239-47. PubMed ID: 8614277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A.
    Murphy JW; Kendall DA
    Biochem Pharmacol; 2003 May; 65(10):1623-31. PubMed ID: 12754098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity.
    Pan X; Ikeda SR; Lewis DL
    Mol Pharmacol; 1998 Dec; 54(6):1064-72. PubMed ID: 9855635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells.
    Abood ME; Ditto KE; Noel MA; Showalter VM; Tao Q
    Biochem Pharmacol; 1997 Jan; 53(2):207-14. PubMed ID: 9037253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.
    Bouaboula M; Perrachon S; Milligan L; Canat X; Rinaldi-Carmona M; Portier M; Barth F; Calandra B; Pecceu F; Lupker J; Maffrand JP; Le Fur G; Casellas P
    J Biol Chem; 1997 Aug; 272(35):22330-9. PubMed ID: 9268384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A.
    Jung M; Calassi R; Rinaldi-Carmona M; Chardenot P; Le Fur G; Soubrié P; Oury-Donat F
    J Neurochem; 1997 Jan; 68(1):402-9. PubMed ID: 8978752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
    Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.
    Gouldson P; Calandra B; Legoux P; Kernéis A; Rinaldi-Carmona M; Barth F; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 2000 Jul; 401(1):17-25. PubMed ID: 10915832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice.
    Darmani NA; Pandya DK
    J Neural Transm (Vienna); 2000; 107(8-9):931-45. PubMed ID: 11041273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.
    Shire D; Calandra B; Rinaldi-Carmona M; Oustric D; Pessègue B; Bonnin-Cabanne O; Le Fur G; Caput D; Ferrara P
    Biochim Biophys Acta; 1996 Jun; 1307(2):132-6. PubMed ID: 8679694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
    FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB; Compton DR; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.
    Gueudet C; Santucci V; Rinaldi-Carmona M; Soubrié P; Le Fur G
    Neuroreport; 1995 Jul; 6(10):1421-5. PubMed ID: 7488739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study.
    Bass CE; Griffin G; Grier M; Mahadevan A; Razdan RK; Martin BR
    Pharmacol Biochem Behav; 2002 Dec; 74(1):31-40. PubMed ID: 12376150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, expression, and characterization of a synthetic human cannabinoid receptor and cannabinoid receptor/ G-protein fusion protein.
    Farrens DL; Dunham TD; Fay JF; Dews IC; Caldwell J; Nauert B
    J Pept Res; 2002 Dec; 60(6):336-47. PubMed ID: 12464112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor.
    Chin CN; Murphy JW; Huffman JW; Kendall DA
    J Pharmacol Exp Ther; 1999 Nov; 291(2):837-44. PubMed ID: 10525107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cannabinoid CB1 receptor antagonist SR 141716A induces penile erection by increasing extra-cellular glutamic acid in the paraventricular nucleus of male rats.
    Succu S; Mascia MS; Sanna F; Melis T; Argiolas A; Melis MR
    Behav Brain Res; 2006 May; 169(2):274-81. PubMed ID: 16516985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.